PregnancyNCT06733272
The Relationship Between Healthy Lifestyle Behaviors, Physical Activity and Blood Tests in Pregnancy
An observational study of Pregnancy, run by Inonu University at 2 sites in Turkey (Türkiye).
Trial summary
Pregnancy is a significant phase in women's lives, marked by psychological, biological, and emotional changes. It lasts for approximately nine months and is divided into three trimesters. Read more about this study
- Who is it for?
- Ages 18 to 40 years, women only
- Conditions the study is for
- Pregnancy
- How many people
- 649 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 15 Aug 2024to 1 Apr 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- Women only
- No healthy volunteers
- Adult
Study population: The study will be conducted between 15.08.2024 and 15.08.2025. The research will be conducted in Kayseri City Hospital Gynecology and Obstetrics Polyclinic and will be conducted as a single center.
Who may be able to join
- Singleton pregnancy
- Maternal age between 18 and 40 years
- In the first trimester of pregnancy
- Literate and capable of understanding written materials
Who cannot join
- Multiple pregnancies
- Non-natural pregnancies
- Family history of thyroid dysfunction
- Presence of thyroid dysfunction and/or autoimmunity
- Clinical diagnosis of Diabetes Mellitus
- Clinical diagnosis of liver disease
Show all 10Show fewer
- Presence of any physical or mental disability
- Chronic endocrine, autoimmune, or metabolic diseases
- Voluntary withdrawal from the study
- Inability to complete the questionnaires included in the study
Trial locations and contacts
2 sites in 1 country.
Turkey (Türkiye)2 sites
Kayseri City Hospital
Kayseri, Turkey, 38030
Kayseri City Hospital
Kayseri, 30080
About this study
Pregnancy is a significant phase in women's lives, marked by psychological, biological, and emotional changes. It lasts for approximately nine months and is divided into three trimesters. Identifying risk factors such as maternal age, gestational age, ethnicity, and lifestyle habits is crucial for managing pregnancy effectively. Anxiety, depression, and stress can significantly impact pregnancy-related responsibilities and overall well-being, making collaboration with a multidisciplinary healthcare team essential.
Physical activity during pregnancy offers numerous benefits, including better physical fitness, improved psychological health, weight management, and reduced risk of gestational diabetes. However, studies show that many women are not sufficiently active, particularly in the first trimester, where activity levels tend to be lower. Regular monitoring of thyroid function (TSH levels) and liver enzymes (ALT, AST) is essential to avoid complications, as pregnancy can affect thyroid function and liver health. Additionally, monitoring hemoglobin and hematocrit levels is necessary to manage pregnancy anemia.
The proposed study aims to evaluate healthy lifestyle behaviors, physical activity, and biochemical markers among pregnant women in the first trimester, using various questionnaires and laboratory tests. This study will provide valuable insights into maternal health and guide clinical practices during early pregnancy to reduce complications and enhance overall outcomes.
Read the detailed description
Pregnancy is a phase in women's lives characterized by psychological, biological, and emotional changes. The process of pregnancy typically spans nine months, divided into three trimesters (Küçükkaya et al., 2018). Identifying risk factors during pregnancy is essential, and these include ethnicity, maternal age, gestational age, antibody presence, iodine sufficiency, parity (number of births), multiple pregnancies, body mass index, and smoking (Curí L.L. et al., 2023). Pregnancy is also linked to various factors that affect a woman's psychological health, family dynamics, and overall quality of life. Pregnant women must collaborate with a multidisciplinary team (doctors, midwives, nurses, physiotherapists, etc.) to manage these risks effectively (Amirshahi et al., 2024).
Pregnant women often experience anxiety about potential negative outcomes during labor and the postpartum period (Küçükkaya et al., 2018). Research indicates that women's concerns and anxieties change across different trimesters (Küçükkaya et al., 2018; Karataylı, S., 2007). Moreover, factors such as age, education level, employment status, and health insurance significantly influence their anxiety levels (Küçükkaya et al., 2018). These concerns-along with anxiety, depression, and stress-affect pregnancy-related responsibilities, nutrition, hygiene, physical activity, travel, and overall acceptance of pregnancy. Therefore, in our study, we plan to assess the healthy lifestyle behaviors of women in their first trimester using the "Pregnancy Healthy Lifestyle Behavior Scale" (Yılmaz E, Karahan N, 2019). This scale, developed by Yılmaz et al., consists of 29 items and 6 subscales (pregnancy responsibility, nutrition, hygiene, physical activity, travel, and pregnancy acceptance) and has undergone validity and reliability testing. It uses a five-point Likert scale, with higher scores indicating more positive health behaviors.
Regular physical activity during pregnancy maintains and improves physical fitness, aids in weight management, reduces the risk of gestational diabetes in obese women, and enhances psychological well-being. It is recommended that women engage in at least 20-30 minutes of moderate-intensity exercise most days of the week. Studies show that physical activity during pregnancy reduces negative outcomes for both the mother and fetus, positively affecting maternal and child health (American College of Obstetricians and Gynecologists, 2015). Physical activity has multiple benefits, including maintaining physical condition, improving quality of life, reducing the risk of obesity-related diseases, and increasing longevity. Generally, physical activity during pregnancy carries minimal risks and benefits most women, particularly those with uncomplicated pregnancies, who are encouraged to engage in personalized exercise programs before, during, and after pregnancy (American College of Obstetricians and Gynecologists, 2015). However, despite its proven benefits, studies have shown that many pregnant women do not engage in adequate physical activity (Göker et al., 2021). Research has found that women's total physical activity levels in the first trimester are lower compared to other trimesters (Lee et al., 2016). Another study shows that physical activity levels increase in the second trimester, with significant improvements noted compared to the first and third trimesters (Özdemir et al., 2017). This decrease in activity in the first trimester may be attributed to efforts to ensure fetal safety and physical discomfort caused by pregnancy (Ko Y-L et al., 2016). However, the pregnancy process is individualized, and some women may engage in regular physical activity even in early pregnancy. Therefore, our study aims to assess physical activity levels in the first trimester. This evaluation will help us understand the frequency of physical activity in early pregnancy and explore its potential effects on pregnancy health. To achieve this, we will use the "Pregnancy Physical Activity Questionnaire" (Chasan-Taber et al., 2004), validated in Turkish by Tosun et al. (2015). This questionnaire consists of 36 items divided into four subscales: occupational activity, household chores, child care, and exercise. The scores will assess the physical activity levels of pregnant women during the first trimester.
Pregnancy also affects thyroid function and can lead to various complications. Factors such as ethnicity, socio-economic status, iodine supplementation, and obesity influence Thyroid-Stimulating Hormone (TSH) levels. Monitoring trimester-specific TSH ranges is important for timely diagnosis and treatment (Yanachkova et al., 2024). Thyroid disorders are common during pregnancy, affecting 2-3% of all pregnancies, with 10% of women having autoimmune thyroid disease despite normal thyroid function. Over the past two decades, a better understanding of thyroid physiology during pregnancy has highlighted the importance of thyroid function adaptation and the negative maternal and neonatal outcomes associated with untreated thyroid disorders, such as hypothyroidism or hyperthyroidism. Increased awareness of thyroid diseases during pregnancy can help reduce complications (Tekin, Y. B., \& Güven, E. S. D., 2014). In our study, we will evaluate TSH values during the first trimester.
In addition to thyroid issues, liver dysfunction during pregnancy can be a concern. Around 3% of pregnancies are affected by liver dysfunction (Ch'ng et al., 2002), which can range from mild functional disturbances to rare severe liver diseases. These issues often arise at specific stages of pregnancy. Proper diagnosis and timely treatment are critical for reducing morbidity and mortality risks for both mother and baby (Güven, S., \& Türkay, C., 2011). Pregnancy-specific liver diseases can cause changes in liver enzymes such as ALT and AST, which are crucial for identifying complications. Therefore, we will examine ALT and AST levels as part of our study.
Monitoring hemoglobin (HGB) and hematocrit (HCT) levels during pregnancy is crucial for the health of both mother and baby. Low HGB and HCT levels can lead to pregnancy-related anemia. In a study examining multiparous women, the anemia rates based on HGB and ferritin levels were found to be 24.2% and 20.8%, respectively (Çıkım et al., 2020). Higher HGB and HCT levels were found in the control group, while the first trimester group had higher values compared to other trimester groups. In preeclamptic pregnancies, higher levels of HGB and HCT are observed in the umbilical cord (Sürücü et al., 2005).
The required sample size for the study has been calculated using G-power analysis, yielding a total of 649 participants. The study is planned to take place from August 15, 2024, to August 15, 2025, at the Kayseri City Hospital's Obstetrics and Gynecology Clinic and will be a single-center study. Participants will complete the Demographic Information Form, Pregnancy Healthy Lifestyle Behavior Scale, and Pregnancy Physical Activity Questionnaire. Biochemical tests, including complete blood count (CBC) and biochemistry tests, will be performed at the Kayseri City Hospital's Medical Biochemistry Laboratory. CBC results will record HGB and HCT levels, while biochemistry results will record TSH, AST, and ALT levels.
- Conditions
- Pregnancy
- Keywords
- Pregnancy, Blood Tests, Physical Activity, Healthy Lifestyle Behaviors
- Medical subject headings
- Motor Activity
What is being measured
The primary outcome is the main question the study is designed to answer.
Biochemistry result
LOWER AND UPPER LIMIT VALUES FOR SERUM TSH; 0.1 - 2.5 mU/L for the first trimester, 0.2 - 3.0 mU/L for the second trimester and 0.3 - 3.0 mU/L for the third trimester. Reference values should be between AST: 5-40 U/L and ALT: 7-56 U/L.
Measured: 1 day
Secondary outcomes (2)
Healthy Lifestyle Behaviors Scale During Pregnancy
"Healthy Lifestyle Behaviors in Pregnant Women Scale" is a five-point Likert-type scale that can be applied to all pregnant women and filled out by the pregnant women themselves. The scale is a measurement tool consisting of a total of 29 items and 6 subscales. Each subscale of the scale can be used alone in studies. Scale items are scored by giving numerical values from 5 to 1 from "always" to "never". There are no reverse-entry items in the scale and high scores obtained from the scale indicate that healthy lifestyle behaviors are positive/high.
Measured: 1 day (A one-time survey when the patient first arrives)
Pregnancy Physical Activity Questionnaire
This scale evaluates 32 activities performed by pregnant women, including housework and care activities, occupational activities, sports and exercise activities, transportation and sedentary life. The intensity of physical activity performed in the scale is expressed as MET (metabolic equivalent). Activity intensities are grouped as sedentary (<1.5 METs), light (1.5-3.0 METs), moderate (3.0-6.0 METs) and vigorous (>0.6 METs).
Measured: 1 day (A one-time survey when the patient first arrives)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Dec 2024
- Study start15 Aug 2024
- Primary completion15 Feb 2025
- Study completion1 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PregnancyStudies of the same condition, open and under way.
- More trials run by Inonu UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 649 participants (actual)
Sponsor and investigators
- Lead sponsor
- Inonu University
- Sponsor type
- University, hospital or other
- Collaborators
- Kayseri City Hospital
- Responsible party
- Principal investigator, Betul Ergun, Inonu University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06733272
- Sponsor's protocol ID
- Pregnancy
- Status last verified
- Nov 2024
- First submitted
- 27 Nov 2024
- Last updated
- 14 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Relationship Between Healthy Lifestyle Behaviors, Physical Activity and Blood Tests in Pregnancy
- ClinicalTrials.gov ID
- NCT06733272
- Acronym / sponsor ID
- Pregnancy
- Conditions
- Pregnancy
- Keywords
- Pregnancy, Blood Tests, Physical Activity, Healthy Lifestyle Behaviors
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 649 participants (actual)
- Lead sponsor
- Inonu UniversityUniversity, hospital or other
- Collaborators
- Kayseri City Hospital
- Study start
- 15 Aug 2024 (actual)
- Primary completion
- 15 Feb 2025 (actual)
- Study completion
- 1 Apr 2025 (actual)
- First posted
- 13 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pregnancy is a significant phase in women's lives, marked by psychological, biological, and emotional changes. It lasts for approximately nine months and is divided into three trimesters. Identifying risk factors such as maternal age, gestational age, ethnicity, and lifestyle habits is crucial for managing pregnancy effectively. Anxiety, depression, and stress can significantly impact pregnancy-related responsibilities and overall well-being, making collaboration with a multidisciplinary healthcare team essential.
Physical activity during pregnancy offers numerous benefits, including better physical fitness, improved psychological health, weight management, and reduced risk of gestational diabetes. However, studies show that many women are not sufficiently active, particularly in the first trimester, where activity levels tend to be lower. Regular monitoring of thyroid function (TSH levels) and liver enzymes (ALT, AST) is essential to avoid complications, as pregnancy can affect thyroid function and liver health. Additionally, monitoring hemoglobin and hematocrit levels is necessary to manage pregnancy anemia.
The proposed study aims to evaluate healthy lifestyle behaviors, physical activity, and biochemical markers among pregnant women in the first trimester, using various questionnaires and laboratory tests. This study will provide valuable insights into maternal health and guide clinical practices during early pregnancy to reduce complications and enhance overall outcomes.
Detailed description
Pregnancy is a phase in women's lives characterized by psychological, biological, and emotional changes. The process of pregnancy typically spans nine months, divided into three trimesters (Küçükkaya et al., 2018). Identifying risk factors during pregnancy is essential, and these include ethnicity, maternal age, gestational age, antibody presence, iodine sufficiency, parity (number of births), multiple pregnancies, body mass index, and smoking (Curí L.L. et al., 2023). Pregnancy is also linked to various factors that affect a woman's psychological health, family dynamics, and overall quality of life. Pregnant women must collaborate with a multidisciplinary team (doctors, midwives, nurses, physiotherapists, etc.) to manage these risks effectively (Amirshahi et al., 2024).
Pregnant women often experience anxiety about potential negative outcomes during labor and the postpartum period (Küçükkaya et al., 2018). Research indicates that women's concerns and anxieties change across different trimesters (Küçükkaya et al., 2018; Karataylı, S., 2007). Moreover, factors such as age, education level, employment status, and health insurance significantly influence their anxiety levels (Küçükkaya et al., 2018). These concerns-along with anxiety, depression, and stress-affect pregnancy-related responsibilities, nutrition, hygiene, physical activity, travel, and overall acceptance of pregnancy. Therefore, in our study, we plan to assess the healthy lifestyle behaviors of women in their first trimester using the "Pregnancy Healthy Lifestyle Behavior Scale" (Yılmaz E, Karahan N, 2019). This scale, developed by Yılmaz et al., consists of 29 items and 6 subscales (pregnancy responsibility, nutrition, hygiene, physical activity, travel, and pregnancy acceptance) and has undergone validity and reliability testing. It uses a five-point Likert scale, with higher scores indicating more positive health behaviors.
Regular physical activity during pregnancy maintains and improves physical fitness, aids in weight management, reduces the risk of gestational diabetes in obese women, and enhances psychological well-being. It is recommended that women engage in at least 20-30 minutes of moderate-intensity exercise most days of the week. Studies show that physical activity during pregnancy reduces negative outcomes for both the mother and fetus, positively affecting maternal and child health (American College of Obstetricians and Gynecologists, 2015). Physical activity has multiple benefits, including maintaining physical condition, improving quality of life, reducing the risk of obesity-related diseases, and increasing longevity. Generally, physical activity during pregnancy carries minimal risks and benefits most women, particularly those with uncomplicated pregnancies, who are encouraged to engage in personalized exercise programs before, during, and after pregnancy (American College of Obstetricians and Gynecologists, 2015). However, despite its proven benefits, studies have shown that many pregnant women do not engage in adequate physical activity (Göker et al., 2021). Research has found that women's total physical activity levels in the first trimester are lower compared to other trimesters (Lee et al., 2016). Another study shows that physical activity levels increase in the second trimester, with significant improvements noted compared to the first and third trimesters (Özdemir et al., 2017). This decrease in activity in the first trimester may be attributed to efforts to ensure fetal safety and physical discomfort caused by pregnancy (Ko Y-L et al., 2016). However, the pregnancy process is individualized, and some women may engage in regular physical activity even in early pregnancy. Therefore, our study aims to assess physical activity levels in the first trimester. This evaluation will help us understand the frequency of physical activity in early pregnancy and explore its potential effects on pregnancy health. To achieve this, we will use the "Pregnancy Physical Activity Questionnaire" (Chasan-Taber et al., 2004), validated in Turkish by Tosun et al. (2015). This questionnaire consists of 36 items divided into four subscales: occupational activity, household chores, child care, and exercise. The scores will assess the physical activity levels of pregnant women during the first trimester.
Pregnancy also affects thyroid function and can lead to various complications. Factors such as ethnicity, socio-economic status, iodine supplementation, and obesity influence Thyroid-Stimulating Hormone (TSH) levels. Monitoring trimester-specific TSH ranges is important for timely diagnosis and treatment (Yanachkova et al., 2024). Thyroid disorders are common during pregnancy, affecting 2-3% of all pregnancies, with 10% of women having autoimmune thyroid disease despite normal thyroid function. Over the past two decades, a better understanding of thyroid physiology during pregnancy has highlighted the importance of thyroid function adaptation and the negative maternal and neonatal outcomes associated with untreated thyroid disorders, such as hypothyroidism or hyperthyroidism. Increased awareness of thyroid diseases during pregnancy can help reduce complications (Tekin, Y. B., \& Güven, E. S. D., 2014). In our study, we will evaluate TSH values during the first trimester.
In addition to thyroid issues, liver dysfunction during pregnancy can be a concern. Around 3% of pregnancies are affected by liver dysfunction (Ch'ng et al., 2002), which can range from mild functional disturbances to rare severe liver diseases. These issues often arise at specific stages of pregnancy. Proper diagnosis and timely treatment are critical for reducing morbidity and mortality risks for both mother and baby (Güven, S., \& Türkay, C., 2011). Pregnancy-specific liver diseases can cause changes in liver enzymes such as ALT and AST, which are crucial for identifying complications. Therefore, we will examine ALT and AST levels as part of our study.
Monitoring hemoglobin (HGB) and hematocrit (HCT) levels during pregnancy is crucial for the health of both mother and baby. Low HGB and HCT levels can lead to pregnancy-related anemia. In a study examining multiparous women, the anemia rates based on HGB and ferritin levels were found to be 24.2% and 20.8%, respectively (Çıkım et al., 2020). Higher HGB and HCT levels were found in the control group, while the first trimester group had higher values compared to other trimester groups. In preeclamptic pregnancies, higher levels of HGB and HCT are observed in the umbilical cord (Sürücü et al., 2005).
The required sample size for the study has been calculated using G-power analysis, yielding a total of 649 participants. The study is planned to take place from August 15, 2024, to August 15, 2025, at the Kayseri City Hospital's Obstetrics and Gynecology Clinic and will be a single-center study. Participants will complete the Demographic Information Form, Pregnancy Healthy Lifestyle Behavior Scale, and Pregnancy Physical Activity Questionnaire. Biochemical tests, including complete blood count (CBC) and biochemistry tests, will be performed at the Kayseri City Hospital's Medical Biochemistry Laboratory. CBC results will record HGB and HCT levels, while biochemistry results will record TSH, AST, and ALT levels.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 40 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- The study will be conducted between 15.08.2024 and 15.08.2025. The research will be conducted in Kayseri City Hospital Gynecology and Obstetrics Polyclinic and will be conducted as a single center.
Key inclusion criteria (4 listed)
- Singleton pregnancy
- Maternal age between 18 and 40 years
- In the first trimester of pregnancy
- Literate and capable of understanding written materials
Key exclusion criteria (10 listed)
- Multiple pregnancies
- Non-natural pregnancies
- Family history of thyroid dysfunction
- Presence of thyroid dysfunction and/or autoimmunity
- Clinical diagnosis of Diabetes Mellitus
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Biochemistry result
Time frame: 1 day
LOWER AND UPPER LIMIT VALUES FOR SERUM TSH; 0.1 - 2.5 mU/L for the first trimester, 0.2 - 3.0 mU/L for the second trimester and 0.3 - 3.0 mU/L for the third trimester. Reference values should be between AST: 5-40 U/L and ALT: 7-56 U/L.
2 secondary outcomes
Healthy Lifestyle Behaviors Scale During Pregnancy
Time frame: 1 day (A one-time survey when the patient first arrives)
Pregnancy Physical Activity Questionnaire
Time frame: 1 day (A one-time survey when the patient first arrives)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jul 2025.
Related trials for Pregnancy
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children
Pyelonephritis
Active, not recruitingPhase 3
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
Carcinoma, Renal Cell
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pregnancy, run by Inonu University at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Biochemistry result (time frame: 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2025.